Exploring the possibility for a pervasive technology solution to facilitate effective diabetes self-care for patients with gestational diabetes

Gestational diabetes(GDM) is increasing exponentially. To address this, we contend that a pervasive mobile solution that can facilitate self-care is a prudent strategy. To demonstrate proof of concept, user fidelity, usability and acceptability of such a solution a small pilot study of 10 patients was designed. A quasi-experimental approach employing a randomized control trial with a two period cross-over clinical trial strategy over 10 week duration at a private hospital in Melbourne, Australia was adopted. The main outcomes of interest were to establish proof of concept and the fidelity of the technology solution. Directional data gathered including patient and clinical interview data serve to demonstrate both proof of concept and fidelity. Without exception both patients and clinicians have preferred the pervasive mobile solution to the standard care approach. The study serves to highlight that pervasive mobile solutions can provide a useful adjunct in the effective monitoring and management of GDM.